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Abstract Objective: Hypothalamic centers integrate external signals of nutrient availability and energy
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doi:10.1016/j.nut.2009status and initiate responses to maintain homeostasis. Quantifying changes in hypothalamic
gene expression in the presence of nutrient excess may identify novel responsive elements.
Methods: Affymetrix Mouse Genome 430 2.0 oligonucleotide microarrays containing 45 102 probe
sets were used to interrogate differential expression of genes in dietary-induced obesity model
C57BL6 inbred mice fed a high-fat (35% fat; n¼ 8) or standard (4% fat; n¼ 6) diet from 3 to 15
wk of age. Ontologies of regulated genes were examined and expression of selected genes was vali-
dated by quantitative real-time polymerase chain reaction.
Results: One thousand two hundred twelve unique gene transcripts showed altered expression on the
microarrays. Gene ontology analysis revealed changes in neuropeptide genes responding to leptin,
Pomc, Cart, Npy, and Agrp, compatible with a homeostatic response to high-fat intake, although
mean weight increased 2.3-fold compared with standard fed mice (P< 0.001). Neurotransmitter sys-
tem ontologies revealed upregulation of five genes controlling availability of dopamine. Changes in Th
tyrosine hydroxylase (2.1-fold) and Slc18a2 solute carrier family 18 (vesicular monoamine), member
2 (4.4-fold) controlling synthesis and release, and Slc6a3 solute carrier family 6 (neurotransmitter
transporter, dopamine), member 3 (4.8-fold), Snca a-synuclein (1.3-fold), and Maoa monoamine
oxidase (1.9-fold) limiting availability were confirmed by quantitative real-time polymerase chain
reaction.
Conclusion: Expression of five genes involved in availability of dopamine was increased after
a high-fat diet. Failure to reduce dopamine availability sufficiently, to counter the feeding reward
effect, could contribute to diet-induced obesity in these mice.  2010 Elsevier Inc.
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Energy homeostasis is maintained by multiple mecha-
nisms that gather information on nutritional status and
make appropriate behavioral and metabolic responses to
changes in fuel availability [1]. Hormones such as leptin
and insulin and nutrients such as glucose and fatty acids
are key peripheral messengers, which communicate energy
status to hypothalamic centers involved in energy homeosta-
sis: the arcuate nucleus (ARC), ventromedial nucleus,
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(PVN) [2]. Analysis of transcriptional changes in the hypo-
thalamus could potentially lead to the discovery of new
elements that may modulate the response to nutrient intake.
Oligonucleotide microarrays have been used to interro-
gate differential expression of a large number of genes under
conditions of energy excess or deficit in various tissues
(reviewed by Sun [3]). Previous studies have investigated
expression profiles in response to food deprivation in the
whole hypothalamus [4] or in different brain nuclei or subre-
gions [5,6]. Others have profiled gene expression in the hypo-
thalamus of rats made obese by a high-energy diet [7,8]. We
present the results of a preliminary study in which we exam-
ined differential expression of hypothalamic genes in the
dietary-induced obesity model inbred mouse C57BL6 in
response to a high-fat or standard chow diet. We extracted
RNA from intact hypothalami and analyzed expression levels
using microarrays containingw45 000 probes forw34 000
known mouse genes. Altered expression of several genes of
interest was validated by quantitative real-time polymerase
chain reaction (qRT-PCR).
To gain a better understanding of any underlying biolog-
ical phenomena, we used Onto-Express, a tool designed to
mine the available functional annotation data and find rele-
vant biological processes [9]. It incorporates Gene Ontology
(GO) project terms [10] in three structured ontologies
describing gene products in terms of their associated biolog-
ical processes, cellular components, and molecular functions.
We input the 1511 Affymetrix probe identifications showing
a difference in expression between high-fat–fed and control-
fed mice. Among biological processes, the most predominant
GO terms included neuropeptide signaling pathways, and
among the molecular function terms, we further examined
those related to neurotransmitter systems. We identified
five genes involved in molecular functions related to dopa-
mine, a critical food intake-related neurotransmitter in the
hypothalamus [11], with release rapidly increased in the ven-
tromedial nucleus during spontaneous eating [12]. Dopamine
is also released in the midbrain ventral tegmental area and
nucleus accumbens during consumption of food, facilitating
motivational behaviors directed toward its acquisition
[13,14]. We report changes in the expression of neuropeptide
and neurotransmitter genes in the high-fat–fed mouse that
may represent imperfect attempts to maintain energy homeo-
stasis in the face of nutrient excess.
Materials and methods
Animals
Fifteen-week-old genetically unaltered female C57BL6/
129SVJ (C57BL6) mice (bred in house) weighing
12.16 0.7 g (mean 6 standard error of the mean) at 3 wk of
age were used in the study. Mice were housed in rooms main-
tained at 216 1 C with relative humidity at 45–65% on a 12-h
light/dark cycle. Mice were fed a standard chow diet (4% fat,6.8% kcal from fat; Rodent Diet RM1E, SDS, Essex, United
Kingdom; n¼ 6) or a high-fat diet (35% fat from lard, 58.4%
kcal from fat; Harlan Teklad, Madison, WI, USA, http://
www.teklad.com/rodent.asp; reference TD.03584; n¼ 8).
Mice were placed on the standard or high-fat diet at 3 wk
of age and were maintained on either diet for 12 wk, until
15 wk of age. The mice were weighed at intervals of 2 wk
from 3 to 15 wk of age (0 to 12 wk on respective diets).
The experiment was terminated at 15 wk by urethane
anaesthesia with 2.5 mg/g of urethane (Sigma-Aldrich, Gil-
lingham, United Kingdom) administered intraperitoneally fol-
lowed by cervical dislocation. For each mouse, three discrete
areas of adipose tissue associated with high-fat diet–induced
obesity were dissected: the abdominal, mesenteric, and dorsal
adipose tissues. The fat pads were then pooled for each mouse
and weighed. The percentage of body weight composed of
adipose tissue was evaluated after death for each mouse. After
death, the skull was cut opened and the brain rotated to expose
the hypothalamus. The hypothalamus was excised, placed into
a 1.5-mL cryotube, snap-frozen in liquid nitrogen, and stored
at80 C for subsequent preparation of total RNA. All proce-
dures were carried out in accordance with the U.K. Home
Office Animals (Scientific Procedures) Act, 1986, and local
ethical committee guidelines.
Analysis of results and statistical evaluation
Results are expressed as mean 6 standard error of the
mean. Statistical analysis was performed using SPSS
(SPSS Inc., Chicago, IL, USA). Statistical evaluation was
carried out using a two-way analysis of variance, followed
by Bonferroni’s test for comparison of means, as required
by the data. P< 0.05 was considered statistically significant.
RNA preparation
One milliliter of prechilled RNAlater-ICE (Ambion, Aus-
tin, TX, USA) was added to each hypothalamus sample and in-
cubated at 20C for at least 16 h to prepare the frozen tissue
for extraction of RNA. Total RNA was isolated from single
hypothalami using the TRIzol Plus RNA purification kit (Invi-
trogen, Paisley, United Kingdom) according to the manufac-
turer’s instructions. Briefly, RNAlater-ICE was replaced
with 1 mL of TRIzol, mixed to homogenize the sample, and
incubated at room temperature for 5 min. The chloroform-
ethanol extract was transferred to the RNA spin cartridge
and centrifuged, followed by washes with buffers I and II.
The RNA was eluted by adding 50 mL of RNase-free water
and centrifuging and then stored at 70C until further use.
Experimental variability was minimized by batch processing
individual hypothalamus samples simultaneously. Before am-
plification and labeling, the quality of the 14 total RNA sam-
ples was determined using the Agilent 2100 Bioanalyzer
equipped with the RNA LabChip (Agilent Technologies,
Palo Alto, CA, USA) according to the manufacturer’s instruc-
tions. The RNA integrity number of the RNA ranged from 8.0
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by 260:280 absorbance ratios) were greater than 1.8 and
28S:18S ratios in the samples exceeded 1.5. All samples
were therefore of sufficient quality for expression-level
analysis.
Microarray hybridization and data analysis
Seven hundred fifty nanograms of total RNA was converted
to biotin-labeled cRNA using the MessageAmp II-Biotin
Enhanced kit (Ambion). To minimize individual variation as
a source of gene-expression variance, RNA samples were
pooled, one pool representing the six control-fed mice (125
ng from each sample) and one representing the eight high-
fat–fed mice (93.8 ng from each sample). Briefly, total RNA
was reverse-transcribed using a T7 oligo(dT) primer to synthe-
size first-strand cDNA. The cDNA then underwent second-
strand synthesis employing DNA polymerase and RNAse H
to simultaneously degrade RNA and synthesize second-strand
cDNA. After purification, the double-stranded DNA was used
as a template for an in vitro transcription reaction containing
biotin-modified uridine triphosphate and T7 RNA polymerase.
The resulting biotin-labeled cRNA was purified to remove
unincorporated nucleoside triphosphates, salts, enzymes, and
inorganic phosphate.
For each cRNA, 15.5 mg was fragmented at 94C for 35 min
in fragmentation buffer (40 mM Tris-acetate, pH 8.1; 100 mM
potassium acetate; 30 mM magnesium acetate). The sizes of
the fragments were analyzed using the Agilent Bioanalyzer.
Two hundred seventy mL of hybridization cocktail master
mix was added to 30 mL of fragmented cRNA, producing
300 mL containing 50 pM control oligo B2, 13 eukaryotic hy-
bridization controls, 0.1 mg/mL of herring sperm DNA,
0.5 mg/mL of acetylated bovine serum albumin, 13 hybridiza-
tion buffer, and 10% dimethylsulfoxide. The arrays were
prehybridized with 250 mL of 13 hybridization buffer for
10 min at 45C with rotation at 60 rpm in a hybridization
oven. The buffer was then removed and 200 mL of hybridiza-
tion cocktail from the experimental and control samples was
then hybridized to the Affymetrix Mouse Genome 430 2.0
oligonucleotide microarrays at 45C for 16 h with rotation at
60 rpm. The arrays were then transferred to the Gene Chip
Fluidics Station 400 (Affymetrix, Santa Clara, CA, USA).
For each chip, 1200 mL of stain solution (13 stain buffer,
2 mg/mL of acetylated bovine serum albumin, and 0.01 mg/
mL streptavidin/phycoerythrin) was prepared and aliquoted
into two batches, and 600 mL of antibody solution (13 stain
buffer, 2 mg/mL of acetylated bovine serum albumin, 1 mg/
mL of normal goat immunoglobulin G, and 3 mg of biotiny-
lated antibody) was prepared. The arrays were stained with
stain solution, followed by antibody and finally stain solution.
Arrays were scanned for fluorescent signals using the
Affymetrix GCS3000 GeneChip Scanner. After scanning,
images were analyzed using Microarray Analysis Suite 5.0 al-
gorithms with the default settings, in the GeneChip Operating
Software (Affymetrix), to generate raw data in the form ofCEL files. Data were globally scaled to correct for any small
variations in hybridization efficiency, laser power, etc., and
comparison analyses were set up in GeneChip Operating Soft-
ware. We first made a preliminary selection that removed all
probe sets for which control- and high-fat–fed samples pro-
duced an ‘‘absent’’ call (detection P 0.065), according to
Affymetrix’s test for the presence of a transcript, followed
by removal of ‘‘no-change’’ calls, where no significant differ-
ence was observed between control- and high-fat–fed samples
(change P¼ 0.002667 to 0.997333).
Analysis of gene expression by qRT-PCR
Quantitative RT-PCR was used to confirm the microarray
results for the expression levels of seven genes. Total RNA
from three control- and three high-fat–fed mouse hypotha-
lamic RNA samples was first reverse-transcribed into
cDNA using the Enhanced Avian RT First-Strand Synthesis
Kit (Sigma, St. Louis, MO, USA) in a 20-mL reaction con-
taining 1 mg of RNA and random nonamer primers. Control
reactions, omitting reverse transcriptase, were also per-
formed. Sensitive, high-throughput assays were designed,
optimized, and run for each gene using the SYBR Green
JumpStart Taq ReadyMix (Sigma) and the ABI 7000
sequence detector (Applied Biosystems, Foster City, CA,
USA). Each 25-mL reaction contained approximately
100 pg of cDNA and 200 mM of each primer. Primers were
designed by Sigma, applied to mouse cDNA sequences
derived from the National Center for Biotechnology Informa-
tion website (http://www.ncbi.nlm.nih.gov), and are listed in
Table 1. Primers were tested with (non-quantitative) PCR to
optimize reaction conditions to generate a single PCR prod-
uct, as shown by gel electrophoresis. Primer sets producing
multiple bands were discarded and redesigned. Ribosomal
protein L19 (Rpl19) was used as a housekeeping gene. An
identical cycle profile was used for all genes: 94C for 2 min -
þ (94C for 15 sþ 60C for 1 minþ 72C for 1 min)3 45
cycles followed by a dissociation stage. Gene-expression
levels were calculated with the relative quantitation method
[15] and normalized to the Rpl19 level.
All PCR reactions were carried out in duplicate. To make
accurate comparisons among samples and adjust target gene
data for the control gene Rpl19, the efficiency of the two PCR
reactions must be similar. Dilutions of cDNA were run in
triplicate using the optimal primer concentrations. The aver-
age threshold cycle (Ct) value for each dilution was plotted
against the log of the input cDNA amount to evaluate linear-
ity of the assay. To find the relative efficiency, the difference
between average target gene Ct and average control gene Ct
(6Ct) for each dilution was plotted against the log-input
cDNA amounts. A slope with an absolute value <0.1 indi-
cates that the efficiencies of the target gene and control
gene reactions are similar, allowing the comparative Ct
method to be used for relative quantification. In validation
experiments, each assay found to be linear over three dilu-
tions. The absolute values of the slope for each comparison
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Fig. 1. Change in body weight of female C57BL6 mice. Mice were fed a nor-
mal (n¼ 6) or high-fat (35%, n¼ 8) diet from 0 to 12 wk (3 to 15 wk of age).
*** Statistical evaluation of mean6 SEM, P< 0.001 by two-way analysis
of variance with Bonferroni’s correction.
Table 1
Primer sequences for gene expression analysis by quantitative real-time polymerase chain reaction
Gene Forward (50–30) Reverse (50–30) Size (bp) Accession no.
Pomc AGAACGCCATCATCAAGAAC AAGAGGCTAGAGGTCATCAG 109 NM_008895
Npy GTGGATCTCTTCTCTCACAGAGG GCCCAAACACACGAGCAGAG 143 NM_023456
Maoa GGAGAAGCCCAGTATCACAGG GAACCAAGACATTAATTTTGTATTCTGAC 113 NM_173740
Slc6a3 GCATCCTGTTCACATATTACAC TTGTCTCCCAACCTGAATTC 144 NM_010020
Slc18a2 TGATCCTGTTCATCGTGTTCCTC GCTGGGAATGATGGGAACTACG 77 NM_172523
Snca TGTACAGTGTGTTTCAAAGTCTTCC GAAGCCACAACAATATCCACAGC 129 NM_001042451
Th CCCCACCTGGAGTACTTTGTG CTTGTCCTCTCTGGCACTGC 111 NM_009377
Maoa, monoamine oxidase; Npy, neuropeptide Y; Pomc, pro-opiomelanocortin; Slc18a2, solute carrier family 18 (vesicular monoamine), member 2 (vesicular
monoamine transporter-2); Slc6a3, solute carrier family 6 (neurotransmitter transporter, dopamine), member 3; Snca, a-synuclein; Th, tyrosine hydroxylase.
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targets. Thus the Rp119 assay could be used to accurately ad-
just target gene data. The qRT-PCR analyses were performed
on RNA samples from three standard-fed and three high-fat–
fed mice. The mean fold change of expression in high-fat–fed
mice compared with standard-fed mice was calculated using
the 2DDCt method [16] and the range of the fold changes was
calculated from the standard error of the DDCt values.
Bioinformatics
To perform an analysis of GO functional categories ac-
cording to the Gene Ontology Consortium (http://www.
geneontology.org), we used a freely available software pack-
age Onto-Express (available at http://vortex.cs.wayne.edu/
projects.htm#Onto-Express) [9]. Onto-Express searches the
public databases and constructs functional profiles using
GO terms [10]. We searched the following categories: cellu-
lar component, biological process, and molecular function.
The result of these analyses is a functional profile of the con-
dition studied, accompanied by the computation of signifi-
cance values for each functional category. Significant
biological processes are distinguished from random events
by comparing the actual number of occurrences with the
expected number for each category.
Results
Phenotypic changes in high-fat–fed mice compared
with controls
The mice gained weight from 3 to 15 wk, as shown in
Figure 1. The mice on the standard diet exhibited a stable
weight from 11 wk of age; those on the 35% high-fat diet con-
tinued to gain weight throughout the experimental period. The
mean weight6 standard error of the mean of the mice at 3 wk
of age was 12.16 0.7 g and increased to 21.56 0.39 g
(n¼ 6) on the standard diet (gain 9.4 g) and 33.96 0.75 g
(n¼ 8) on the high-fat diet (gain 21.8 g) by 15 wk of age.
High-fat–fed mice therefore gained 2.32 times more weight
in 12 wk than their standard-fed littermates. The differences
in mean weights between high-fat- and standard-fed mice
were highly significant (P< 0.001) from age 9 wk onward(6 wk on diets). In these mice, the percentage of body weight
comprised of adipose tissue in the three pooled major fat pads
was significantly different at termination: 2.46 0.3% (n¼ 6)
for mice fed a standard diet and 16.66 0.9% (n¼ 8) for
mice fed the high-fat diet (P< 0.0001).
Microarray analysis
After removing all probe sets on the Affymetrix Mouse
Genome 430 2.0 gene chip array for which control- and
high-fat–fed samples produced an ‘‘absent’’ or ‘‘no-change’’
call, 1511 probe sets indicated a difference in gene expression
between high-fat–fed and control-fed mice. The identifications
of the 1511 probe sets and the .CEL level data (probe cell data)
are available as an online supplement (Online Table 1). These
probes represented 1212 unique gene transcripts with altered
expression, of which 616 (50.8%) were upregulated and 596
(49.2%) were downregulated. The full results, showing the
1212 unique gene transcripts and fold changes in expression
in high-fat–fed compared with control-fed mice, are available
as an online supplement (Online Table 2). Tables 2 and 3 pres-
ent the genes on this list, with the greatest changes in expression
in response to the high-fat diet. There were 45 genes with
expression increased by 2.0-fold or more in high-fat–fed
mice compared with controls (Table 2) and 38 genes with
Table 2
Genes with expression increased after high-fat diet by at least two-fold compared with standard diet*
Probe identification Fold change Gene symbol Gene name
1418047_at 13.00 Neurod6 Neurogenic differentiation-6
1434802_s_at 6.06 Ntf3 Neurotrophin-3
1419230_at 5.28 Krt1-12 RIKEN cDNA A830036E02 gene
1445228_at 4.59 Spred1 Sprouty protein with EVH-1 domain 1, related sequence
1417415_at 3.48 Slc6a3 Solute carrier family 6 (neurotransmitter transporter, dopamine), member 3
1424649_a_at 3.25 Tm4sf3 Tetraspanin-8
1441107_at 3.03 Dmrta2 Doublesex and mab-3 related transcription factor-like family A2
1446627_at 3.03 Stk3 Serine/threonine kinase-3 (Ste20, yeast homolog)
1445555_at 2.83 Trpm3 Transient receptor potential cation channel, subfamily M, member 3
1418271_at 2.64 Bhlhb5 Basic helix-loop-helix domain containing, class B5
1421944_a_at 2.64 Asgr1 Asialoglycoprotein receptor 1
1445552_at 2.64 Mlr1 Ligand dependent nuclear receptor corepressor-like
1447869_x_at 2.64 Rhobtb3 Rho-related BTB domain containing 3
1448265_x_at 2.64 Eva1 Epithelial V-like antigen 1
1451191_at 2.64 Crabp2 Cellular retinoic acid binding protein II
1417072_at 2.46 Slc22a6 Solute carrier family 22 (organic anion transporter), member 6
1424679_at 2.46 Mab21l1 Mab-21–like 1 (Clostridium elegans)
1428986_at 2.46 Slc17a7 Solute carrier family 17 (sodium-dependent inorganic
phosphate cotransporter), member 7
1430460_at 2.46 5830410F13Rik RIKEN cDNA 2310047O13 gene
1437244_at 2.46 Gas2l3 Growth arrest-specific 2 like 3
1440488_at 2.46 Ptpn4 Protein tyrosine phosphatase, non-receptor type 4
1447567_at 2.46 Odz3 Odd Oz/ten-m homolog-3 (Drosophila)
1457656_s_at 2.46 C230085N15Rik RIKEN cDNA C230085N15 gene
1419662_at 2.30 Ogn Osteoglycin
1443012_at 2.30 Tcf12 Transcription factor 12
1449254_at 2.30 Spp1 Secreted phosphoprotein 1
1450427_at 2.30 Chrna6 Cholinergic receptor, nicotinic, a-polypeptide 6
1452473_at 2.30 E130201N16Rik Proline rich 15
1416236_a_at 2.14 Eva1 Epithelial V-like antigen 1
1426852_x_at 2.14 Nov Nephroblastoma overexpressed gene
1442785_at 2.14 A130004G11Rik RIKEN cDNA A130004G11 gene
1443131_at 2.14 Lrp1b Low-density lipoprotein–related protein 1B (deleted in tumors)
1443337_at 2.14 B130020M22Rik RIKEN cDNA B130020M22 gene
1443783_x_at 2.14 H2-Aa Histocompatibility 2, class II antigen A, a
1459369_at 2.14 Epha6 Eph receptor A6
1419663_at 2.00 Ogn Osteoglycin
1419665_a_at 2.00 Nupr1 Nuclear protein 1
1421477_at 2.00 Cplx2 Complexin 2
1426851_a_at 2.00 Nov Nephroblastoma overexpressed gene
1429537_at 2.00 5730406M06Rik RIKEN cDNA 5730406M06 gene
1430770_at 2.00 3110080E11Rik RIKEN cDNA 3110080E11 gene
1431248_at 2.00 5031426D15Rik RIKEN cDNA 5031426D15 gene
1435290_x_at 2.00 H2-Aa Histocompatibility 2, class II antigen A, a
1444152_at 2.00 Cugbp2 CUG triplet repeat, RNA binding protein 2
1457555_at 2.00 Gpr151 G-protein–coupled receptor 151
1458263_at 2.00 Cugbp2 CUG triplet repeat, RNA binding protein 2
* Two-fold signifies expression after high-fat diet is increased to 200% level after the standard diet.
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of the control levels (Table 3).
Gene ontology
To gain a better understanding of any underlying biolog-
ical phenomena, we used Onto-Express [9], a tool designed
to mine the available functional annotation data and find rel-
evant biological processes (see MATERIALS AND METHODS). It
incorporates GO project terms [10] in three structured ontol-
ogies that describe gene products in terms of their associatedbiological processes, cellular components, and molecular
functions. We input the 1511 Affymetrix probe identifica-
tions showing a difference in gene expression between
high-fat–fed and control-fed mice. The significance of gene
representation in each GO term is computed from the number
of regulated genes and the number of genes on the microar-
ray. The tree view displays the results in the same format
as the ontology from the Gene Ontology Consortium. Expan-
sion of the tree allows identification of the individual genes in
each significant GO term. An overview is provided by the
tabulated output for GO terms in various functional
Table 3
Genes with expression decreased after high-fat diet by 0.5-fold compared with standard diet*
Probe identification Fold change Gene symbol Gene name
1417109_at 0.50 Lcn7 Tubulointerstitial nephritis antigen-like
1422410_at 0.50 Ferd3l Fer3-like (Drosophila)
1423424_at 0.50 Zic3 Zinc finger protein of the cerebellum 3
1424272_at 0.50 Stat3 Signal transducer and activator of transcription 3
1434574_at 0.50 9430008C03Rik RIKEN cDNA 9430008C03 gene
1435370_a_at 0.50 Ces3 Carboxylesterase 3
1438086_at 0.50 Npy6r Neuropeptide Y receptor Y6
1440519_at 0.50 Sp8 Trans-acting transcription factor 8
1448890_at 0.50 Klf2 Kruppel-like factor 2 (lung)
1454608_x_at 0.50 Ttr Transthyretin
1455913_x_at 0.50 Ttr Transthyretin
1459737_s_at 0.50 Ttr Transthyretin
1419300_at 0.47 Flt1 FMS-like tyrosine kinase 1
1428664_at 0.47 Vip Vasoactive intestinal polypeptide
1439627_at 0.47 Zic1 Zinc finger protein of the cerebellum 1
1457094_at 0.47 She src homology 2 domain-containing transforming protein E
1426732_at 0.44 Des Desmin
1441924_x_at 0.44 Edn3 Endothelin 3
1451617_at 0.44 Rho Rhodopsin
1440926_at 0.41 Flt1 FMS-like tyrosine kinase 1
1450371_at 0.41 Tshb Thyroid-stimulating hormone, b subunit
1439427_at 0.38 Cldn9 Claudin 9
1424107_at 0.35 Kif18a Kinesin family member 18A
1421690_s_at 0.33 Agrp Agouti related protein
1450293_at 0.33 Mageb3 Melanoma antigen, family B, member 3
1419974_at 0.31 Scp2 Sterol carrier protein 2, liver
1424794_at 0.31 9130020G10Rik Ring finger protein 186
1446059_at 0.31 2900086E13Rik RIKEN cDNA 2900086E13 gene
1436835_at 0.23 Crk v-crk sarcoma virus CT10 oncogene homolog (avian)
1438737_at 0.20 Zic3 Zinc finger protein of the cerebellum 3
1459356_at 0.15 Dst Dystonin
1445657_at 0.13 AW111846 Expressed sequence AW111846
1427727_x_at 0.13 Psg19 Pregnancy-specific glycoprotein 19
1441896_x_at 0.11 Obfc1 Oligonucleotide/oligosaccharide-binding fold containing 1
1441650_at 0.09 Arhgap15 Rho GTPase activating protein 15
1427303_at 0.09 Enpp3 Ectonucleotide pyrophosphatase/phosphodiesterase 3
1458004_at 0.07 Prrx1 Paired related homeobox 1
1449844_at 0.06 Slco1a1 Solute carrier organic anion transporter family, member 1a1
1420112_at 0.05 Pacs1 Phosphofurin acidic cluster sorting protein 1
1441504_at 0.04 Gm817 Gene model 817 (NCBI)
1442433_at 0.04 Pcna Proliferating cell nuclear antigen
1459570_at 0.02 Gpr143 G-protein–coupled receptor 143
* 0.5-fold signifies expression after high-fat diet is reduced to 50% of level after the standard diet.
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categories, 1) cellular component, 2) biological process, and
3) molecular function, are shown in Figure 2.
Among cellular components, the most significantly rep-
resented were cell membrane, extracellular space, and
cytoplasm, structures integral to the membrane, the endo-
plasmic reticulum, and nucleus (all Ps< 0.0001). Among
biological processes, the most predominant related to tran-
scription and neuropeptide signaling pathways (P< 0.001).
Less significant were regulation of transcription and cell ad-
hesion (P< 0.01). Among molecular functions, many types
of binding activity featured the more widespread, calcium
ion, nucleotide, DNA, and nuclear hormone receptor, and
the more specific, heparin, calmodulin, and retinol. Various
enzyme activities were represented, including nucleotidediphosphatase, phosphodiesterase I and kinase, and tran-
scriptional repressors (Ps¼ 0.0017 to 0.044).
Expansion of the tree view allows further interrogation of
GO terms. Among biological processes, we found significant
representation in neuropeptide signaling pathways. Among
molecular functions, we investigated GO terms linked to
receptors, synthetic enzymes, and transporters of cholinergic,
dopaminergic, adrenergic, g-aminobutyric acidergic, gluta-
matergic, or serotonergic neurotransmitter systems.
Genes involved in neuropeptide signaling
Four index genes in the neuropeptide signaling pathway
(GO:0007218), with well-documented evidence of a role
in energy homeostasis, showed predicted alterations in
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Fig. 2. Change in gene expression by high-fat feeding. Significant representation in Gene Ontology 1511 probes indicated a difference in gene expression
between high-fat–fed (n¼ 8) and control-fed (n¼ 6) mice. This subset was processed using Onto-Express to categorize the genes according to (a) biological
process, (b) cellular component, and (c) molecular function. In each group, significant functions were distinguished from random events by comparing the actual
number of occurrences with the expected number for each Gene Ontology term, predicted by probe representation on the microarray. The Gene Ontology terms
significantly represented (P< 0.05 in left column) are shown. The length of each bar is proportional to the number of identifiers found in the input file (probe
identifications) that were annotated using the corresponding term. The numbers of probe identifications in parentheses and P values for each term are shown next
to each bar. ER, endoplasmic reticulum; SWI/SNF, SWItch/Sucrose Nonfermentable; VEGF, Vascular endothelial growth factor.
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genic Agrp, agouti-related polypeptide, was downregu-
lated 0.33-fold (33% of standard-fed levels) by high-fat
feeding and Npy, neuropeptide Y, 0.57-fold. Anorexigenic
Cart, cocaine and amphetamine-regulated transcript pre-
propeptide, was upregulated 1.3-fold (30% above standard
fed) and Pomc, proopiomelanocortin, 1.4-fold.Genes involved in neurotransmission
We identified five genes involved in molecular func-
tions related to dopamine. Two were involved with
production and release: Th, tyrosine hydroxylase (up 1.3-
fold), catalyses the rate-limiting biosynthetic step in dopa-
mine synthesis from tyrosine (GO:0006585) and Slc18a2,
solute carrier family 18 (vesicular monoamine), member 2
(up 1.2-fold), is involved in dopamine transmembrane
transporter activity (GO:0005275). Three were involved
with reuptake, regulating transmission, and degradation:
Slc6a3, the dopamine/sodium symporter, is responsible
for dopamine uptake (GO:0005330, up 3.48-fold), Snca
a-synuclein (up 1.1-fold) is a negative regulator of dopa-
mine neurotransmission (GO:00042416), and Maoa mono-
amine oxidase (up 1.2-fold) is involved in dopamine
deamination (GO:0042420).
A number of other regulated genes were involved with dif-
ferent neurotransmitter systems. Viaat, solute carrier family
32 (g-aminobutyric acid vesicular transporter), member 1,
which has g-aminobutyric acid/hydrogen symport activity
(GO:0015495), was downregulated (0.70-fold), as was
Atp2b2 adenose triphosphatase, Ca2þ transporting, plasma
membrane 2 (0.62-fold), involved in the serotonin metabolic
process (GO:0042428). Chrna6 (up 2.3-fold) is involved in
cholinergic synaptic transmission (GO:0005216) and in reg-
ulation of dopamine secretion (GO:0014059). Grm3 and
Grm8, glutamate receptors metabotropic 3 and 8 (both up
1.3-fold), and Cacnb4 calcium channel, voltage-dependent,
b4 subunit (up 1.1-fold), are involved in glutamatergic trans-
mission (GO:0035249).Confirmation of microarray data by qRT-PCR analysis
To validate the microarray analyses of the five genes in-
volved in dopamine availability, Th, Slc18a2, Slc6a3,
Snca, and Maoa, we examined the mRNA levels of these
and two index genes Pomc and Npy by qRT-PCR. The
results of analysis of mRNAs isolated from hypothalami
of three high-fat–fed and three control-fed mice are shown
in Figure 3. The mRNA levels established by qRT-PCR
confirmed the direction of the changes indicated on the ar-
rays and showed higher actual fold changes than indicated
by the microarray data. The fold changes in high-fat–fed
mice compared with controls were as follows: Npy 0.80;
Pomc 2.22; Th 2.10; Slc18a2 4.40; Snca 1.28; Maoa
1.86; and Slc6a3 4.82.Discussion
The hypothalamus maintains energy homeostasis by inte-
grating signals from peripheral sites and producing signaling
molecules in response to changes in energy status [2,17]. In
this preliminary study, we aimed to obtain a broad overview
of the transcriptional changes that accompany this complex
process and possibly identify novel players, using microar-
rays to discover genes whose expression in mice is altered
in response to a high-fat diet. We identified 1212 genes
with altered expression. Regulation of four neuropeptide
genes and five involved in dopaminergic transmission
emerged from the analysis of gene ontology.
We used single arrays for pooled RNA samples from high-
fat- or control-fed mice, which avoided variability in gene-
expression patterns between samples. In a complex action
such as energy balance, numerous genes with small to mod-
erate effects are expected to contribute to variation, with
changes in vivo unlikely to exceed three-fold [4] and consid-
erable variation expected between genes. In mice on the high-
fat diet, we detected increases greater than two-fold in 45
genes and 38 genes were downregulated to less than 50%
of control levels. We chose to analyze all probes signifying
altered expression using Onto-Express software without
imposing a cutoff, so that any showing small yet functionally
significant changes would not be excluded at the outset. We
confirmed changes in expression of seven genes in response
to high-fat feeding by qRT-PCR, suggesting that differences
in levels of mRNA are correlated to diet and the genes are
likely downstream targets of regulation by nutritional state.
The mRNA levels of each gene showed modest variation
among the three mice, with the exception of Slc6a3, where
a divergent response in mice fed the high-fat diet led to a large
statistical range in the mean fold changes. Slc18a2 showed
considerably higher relative expression in the qRT-PCR
than was evident from the microarray data.
Two physiologically opposing populations of ARC neuro-
nes are crucial to energy homeostasis. The first is located pre-
dominantly in the ventromedial ARC and coexpresses the
orexigenic neuropeptides neuropeptide Y and agouti-related
protein. The second is located predominantly in the ventrolat-
eral ARC and coexpresses anorexigenic neuropeptides
derived from the pro-opiomelanocortin prohormone (e.g.,
a-melanocyte–stimulating hormone) and the cocaine- and
amphetamine-regulated transcript. Neural fibers from both
ARC regions project to the paraventricular nucleus, the site
of second-order neuronal signaling [2]. At least two research
groups have microdissected the hypothalamus to examine
gene expression specifically in the ARC [7] or ARC and para-
ventricular nucleus [18,19] in relation to nutrient intake. This
demands exceptional skill and the quantitation of RNA in
very small amounts of material. However, the difficulty of
excision without contamination from adjacent areas means
that these dissections can still be relatively heterogeneous at
the cellular level. In common with a number of other investi-
gators examining the response of hypothalamic genes to the
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Fig. 3. Validation of microarray data by quantitative real-time polymerase
chain reaction. The average level of expression of each gene after the
high-fat diet normalized to Rpl19 and relative to expression on the normal
diet (dashed line) is shown. The error was estimated by evaluating the 2DDCt
term using DDCt6 SD, producing a range of values asymmetrically distrib-
uted relative to the average value, shown by the bars. Maoa, monoamine ox-
idase; Npy, neuropeptide Y; Pomc, pro-opiomelanocortin; Slc18a2, solute
carrier family 18 (vesicular monoamine), member 2 (vesicular monoamine
transporter-2); Slc6a3, solute carrier family 6 (neurotransmitter transporter,
dopamine), member 3; Snca, a-synuclein; Th, tyrosine hydroxylase.
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from the brain. We concede that, in processing the whole tis-
sue, the magnitude of changes that might have been observed
in specific nuclei was inevitably reduced and any opposing
effects in different nuclei would not be seen.
The adipocyte hormone leptin signals levels of peripheral
fat stores to the ARC of the ventral hypothalamus [22]. Most
previous reports of Pomc, Cart, Npy, and Agrp expression
after dietary manipulation have shown a change contrary to
the maintenance of homeostasis or no change in obesity-
prone mice. For example, leptin excites the anorexigenic
Pomc- and Cart-expressing neurons, reducing appetite and
enhancing metabolism [23]. However, in the diet-induced
obese mouse, Pomc and Cart have shown downregulation
[24–26], no change [27,28], and upregulation [29] on
a high-fat diet. Orexigenic Npy and Agrp production is in-
hibited by leptin, so downregulation is the expected response.
In DIO mice elevated Npy expression is usual [27,30–36] and
has been cited as the reason for obesity susceptibility, but
downregulation [27,29,37–39] or no change [28,30,40] has
also been reported. It therefore appears that varying degrees
of homeostatic efficiency by neuropeptides exist in the obe-
sity-prone mouse model. Our microarrays showed changes
in line with a normal homeostatic response to nutrient excess:
increased expression of Pomc and Cart and decreases in Npy
and Agrp after 12 wk on the high-fat diet. However, homeo-
stasis was imperfect because the mice gained more than twice
as much weight, attributable to significantly more adipose tis-
sue, than those on standard chow. Failure of the mice to con-
trol body weight must result from an inability of the changes
in hypothalamic neuropeptide expression alone to effectively
counteract the obesogenic drive of the high-fat intake
mediated by other factors.To identify novel genes involved in response to the high-fat
diet, we focused on receptors, synthetic enzymes and trans-
porters of cholinergic, dopaminergic, adrenergic,g-aminobuty-
ric acidergic, glutamatergic, or serotonergic neurotransmitter
systems, identified through analysis of gene ontology. A group
of five genes with altered expression was directly related to the
activity of dopamine. Th is the gene for tyrosine hydroxylase,
the rate-limiting enzyme in dopamine biosynthesis [41].
Slc18a2 is the gene for solute carrier family 18, member A2 (ve-
sicular monoamine transporter-2), the only transporter that
moves cytoplasmic dopamine into synaptic vesicles for storage
and subsequent exocytotic release [42]. Together, these genes
control dopamine production and exocytosis. Upregulation of
the other three genes reduces dopamine availability. Snca is
the gene fora-synuclein, involved in the regulation of dopamine
biosynthesis [43], release, and transport [44]. Slc6a3 is the gene
for solute carrier family 6, member A3 (neurotransmitter trans-
porter, dopamine), which terminates the action of dopamine by
its high affinity sodium-dependent reuptake into presynaptic ter-
minals [45]. Maoa, the gene for monoamine oxidase, deami-
nates dopamine [46].
Dopamine signals by five G-protein–coupled receptor
subtypes comprising two families. The D1-like receptors
DRD1 and DRD5 activate adenylyl cyclase and the D2-like
receptors DRD2, DRD3, and DRD4 inhibit the enzyme in
postsynaptic neurons [47]. Drugs that block DRD2 enhance
appetite and induce weight gain in animals and humans
[48]. DRD2 and DRD1 agonists have the opposite effect
[49]. The effects of changing dopamine concentration in
the hypothalamus and midbrain on feeding behavior are
well known. Dopamine release increases rapidly in the ven-
tromedial nucleus during spontaneous eating [12] and food
deprivation brings about an immediate decrease [11]. Dopa-
mine levels are elevated in the brains of obese animal models
[12,50], but at the same time, DRD2 expression is decreased
[51]. This has given rise to the idea that enhanced dopamine
release may compensate for the smaller number of receptors
to maintain signal transduction. Food consumption is
a rewarding and highly reinforcing behavior that not only
provides nutrients needed for survival but also induces feel-
ings of gratification [52]. Midbrain dopamine neurons have
long been known to mediate reward behavior and the motiva-
tional aspects of feeding [13,14]. The reward pathway in-
cludes the dopamine neurons in the ventral tegmental area
that project to the nucleus accumbens, and dopamine release
in the rat nucleus accumbens has been shown to relate to the
amount of food ingested [53]. Lack of DRD2 receptors trans-
ducing an appetite-reducing or satiety signal has been pro-
posed to induce a ‘‘reward deficiency syndrome’’ [54] in
which increased release of dopamine in response to large
meals in obese animals compensates for reduced signaling
capability and, hence, its reduced feedback effect on satiety
[51]. Geiger et al. [55] hypothesized that increased food in-
take in underweight animals could be partly attributed to
a compensatory attempt to restore basal mesolimbic dopa-
mine levels. They showed that extracellular basal dopamine
A. K. Lee et al. / Nutrition 26 (2010) 411–422420is low in obesity-prone rats due to reduced activity of tyrosine
hydroxylase and vesicular monoamine transporter-2 and
attributed susceptibility to obesity to an increased motivation
to eat and increase dopamine levels.
Our obesity-prone mice gained more weight on the high-
fat than on the standard diet, but we found no change in
expression of dopamine receptor genes, only those influenc-
ing the availability of dopamine. The net effect of altered
expression of the five genes on extracellular dopamine con-
centration cannot be predicted at present because no measure-
ments were made. An increase would be compatible with
palatable high-fat food evoking a greater surge in dopamine
than the less palatable chow [12], i.e., providing a greater
reward, which would encourage overeating. We cannot com-
ment directly on any stimulatory effect of the palatable high-
fat diet because we did not measure food intake. However,
Chan et al. [56] reported a significant increase in C57BL6
mice on a high-fat diet (21%) compared with a standard diet
after 4 and 10 wk, suggesting that changes in gene expression
in our mice may have been evoked by overnutrition. It would
require a pair-feeding experiment with caloric intake matched
in high-fat–fed and chow-fed controls to establish whether fat
as a dietary constituent or overnutrition per se was the critical
factor in eliciting the observed changes in gene expression.
Mechanisms by which high-fat feeding or caloric excess
could upregulate these genes await further investigation.
The changes may be linked to leptin action because the
mice remained sensitive enough for the normal homeostatic
changes in hypothalamic neuropeptides to be evoked. In ad-
dition to its anorexigenic effects in the hypothalamus, leptin
inhibits the firing of dopamine neurons in the ventral tegmen-
tal area of the midbrain, leading to a decrease in dopamine re-
lease [57] and reduction in reward-driven feeding [58,59].
Alternatively, the genes may respond directly to circulating
nutrients through activation and binding of transcription
factor complexes.
It should be noted that, in addition to its influence on food
intake, dopamine has a potential role in energy balance
through its involvement in thermogenesis. Cold exposure
activates tyrosine hydroxylase, producing a large increase
in dopamine content and turnover rate in brown adipose
tissue [60]. In contrast, activation of central nervous system
dopamine DRD2 receptors inhibits sympathetically mediated
interscapular brown adipose tissue thermogenesis in response
to cold exposure, inducing hypothermia [61]. Therefore, cen-
tral dopamine acting on DRD2 receptors in the hypothalamus
appears to inhibit thermogenesis and appetite without appar-
ent overall directional effect on energy balance.
Obesity is a leading public health issue, categorized by the
World Health Organization as a global epidemic and driven
by the current environment of overabundance of food and
lack of physical activity. Obesity and overweight are major
risk factors for chronic diseases, including type 2 diabetes,
cardiovascular disease, and certain cancers. It is imperative to
understand the mechanisms underlying obesity to devise pre-
vention and treatment strategies. All known monogenic defectscausing human obesity disrupt hypothalamic pathways, affect-
ing satiety and food intake rather than influencing metabolic
rate or deposition of fat. It is likely that genes contributing to
common human obesity will have a similar function. In an en-
vironment with few restraints on food availability, homeostatic
responses to overnutrition mediated by neuropeptides designed
to protect from starvation may be less relevant to targeting the
problem of obesity than pathways involving the hedonic
response to food. The involvement of the dopamine system
in reward and reinforcement has led to the hypothesis that
low brain dopamine activity in obese subjects predisposes to
excessive eating, as a means to compensate for decreased acti-
vation of these circuits. Strategies aimed at improving dopa-
mine function have been shown to be beneficial in the
treatment of obese individuals. This may prove to be a more
productive line of investigation in the quest to solve an increas-
ingly important public health issue in Western societies.
Conclusion
After a high-fat diet, mouse hypothalamic genes for syn-
thesis and release of dopamine were upregulated, as were
those for uptake and degradation, but there was no change
in expression of receptors. Failure to counter the rewarding
effects of dopamine released by overfeeding could contribute
to diet-induced obesity in these mice.
Supplementary data
Supplementary data associated with this article can be
found, in the online version, at doi:10.1016/j.nut.2009.05.007.
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